Why look at the Balance Sheet now

SigmaRoc (LSE:SRC) has published no regulatory news since its third-quarter trading update on 21 October 2026, which kept the board's full-year view unchanged. With trading covered recently, this article turns to the group's financing position as set out in its interim results for the six months to 30 June 2026, published on 7 September, and asks what that position allows. All figures are in sterling unless stated.

Debt falling, cash flowing

Net debt, including Lease liabilities, was £462.6m at 30 June, down 7.2% from £498.4m a year earlier. Covenant leverage, the measure used by its lenders, fell to 1.66 times from 2.04 times. Underlying free Cash Flow for the half rose 8.2% to £67.0m, equal to 51.1% of underlying EBITDA of £131.2m, slightly below the 52.5% conversion of the prior-year period. Return on invested Capital over the last twelve months improved to 11.8% from 11.3%, which the company presented as progress towards best-in-class returns for a European minerals platform.

The company said the improvement reflected solid cash conversion. Underlying EBITDA Margin widened by 200 basis points to 25.1%, and underlying Earnings Per Share rose 12.2% to 5.23p. Analyst consensus quoted by SigmaRoc at the time pointed to year-end Leverage of 1.4 times, although that figure predates the Acquisition announced the same morning.

The new facility

In March 2026 SigmaRoc (LSE:SRC) signed a syndicated revolving Credit Facility of up to €825m led by BNP Paribas, with a further uncommitted €300m accordion, maturing on 26 March 2031. The facility itself is unsecured. Its interest margin ranges from 1.00% to 2.50% above Euribor depending on leverage, and stood at 1.50% for the period. The maximum adjusted leverage covenant is 3.75 times. A separate €125m five-year facility arranged through a US private Placement process in February 2025 also remains in place.

At 30 June the company said undrawn amounts under the facility were about £275m and that it complied comfortably with its covenants. Reported leverage was less than half the covenant ceiling, leaving considerable room before lenders' limits would bind.

Deals before dividends

The board again did not declare an interim dividend, and none was paid in the first half of 2026 or 2025. The company's stated policy is to pay dividends when directors judge it appropriate and prudent. Management has been explicit that the refinancing was designed to increase acquisition capacity for consolidation in European lime and minerals. The €110m purchase of AB Dolomitas in Lithuania, which the company expects to complete later this year, is the first use of that capacity. The priority remains growth through acquisition rather than cash returns, at least while suitable targets are available.

Factors to watch

Higher borrowing to fund acquisitions would reverse some of the deleveraging, and the variable-rate structure exposes SigmaRoc (LSE:SRC) to movements in euro interest rates. Free cash flow conversion of around half of EBITDA reflects capital spending and interest that must continue. Residential construction remained subdued across Europe in the third quarter, the company said, and it remains watchful of Middle East tensions. Two environmental groups have sought leave to appeal the newly granted Klinthagen limestone permit in Sweden to the Supreme Court, although the company said the permit is not suspended.

What to watch

Completion of AB Dolomitas, the commissioning of a new Belgian aggregates plant expected in the second half, and full-year results for 2026 will show how much headroom remains. Nine-month figures released in October showed underlying EBITDA up 7.5% to £207.3m on Revenue of £795m, against consensus full-year underlying EBITDA of £280m quoted by the company, so the fourth quarter needs to contribute roughly £73m of EBITDA. The company has not yet announced a date for those results.